These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27418066)

  • 21. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.
    Swidsinski A; Weber J; Loening-Baucke V; Hale LP; Lochs H
    J Clin Microbiol; 2005 Jul; 43(7):3380-9. PubMed ID: 16000463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease.
    Kuehbacher T; Rehman A; Lepage P; Hellmig S; Fölsch UR; Schreiber S; Ott SJ
    J Med Microbiol; 2008 Dec; 57(Pt 12):1569-1576. PubMed ID: 19018031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Intestinal Microbiota in Inflammatory Bowel Disease.
    Becker C; Neurath MF; Wirtz S
    ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota.
    Altomare A; Putignani L; Del Chierico F; Cocca S; Angeletti S; Ciccozzi M; Tripiciano C; Dalla Piccola B; Cicala M; Guarino MPL
    Dig Liver Dis; 2019 May; 51(5):648-656. PubMed ID: 30573380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
    Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crohn's Disease Differentially Affects Region-Specific Composition and Aerotolerance Profiles of Mucosally Adherent Bacteria.
    Shahir NM; Wang JR; Wolber EA; Schaner MS; Frank DN; Ir D; Robertson CE; Chaumont N; Sadiq TS; Koruda MJ; Rahbar R; Nix BD; Newberry RD; Sartor RB; Sheikh SZ; Furey TS
    Inflamm Bowel Dis; 2020 Nov; 26(12):1843-1855. PubMed ID: 32469069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls.
    Kleessen B; Kroesen AJ; Buhr HJ; Blaut M
    Scand J Gastroenterol; 2002 Sep; 37(9):1034-41. PubMed ID: 12374228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group.
    Peach S; Lock MR; Katz D; Todd IP; Tabaqchali S
    Gut; 1978 Nov; 19(11):1034-42. PubMed ID: 730070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environmental Microbial Factors Determine the Pattern of Inflammatory Lesions in a Murine Model of Crohn's Disease-Like Inflammation.
    Stolzer I; Kaden-Volynets V; Ruder B; Letizia M; Bittel M; Rausch P; Basic M; Bleich A; Baines JF; Neurath MF; Wirtz S; Weidinger C; Bischoff SC; Becker C; Günther C
    Inflamm Bowel Dis; 2020 Jan; 26(1):66-79. PubMed ID: 31276162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum.
    Baumgart M; Dogan B; Rishniw M; Weitzman G; Bosworth B; Yantiss R; Orsi RH; Wiedmann M; McDonough P; Kim SG; Berg D; Schukken Y; Scherl E; Simpson KW
    ISME J; 2007 Sep; 1(5):403-18. PubMed ID: 18043660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.
    De Cruz P; Kang S; Wagner J; Buckley M; Sim WH; Prideaux L; Lockett T; McSweeney C; Morrison M; Kirkwood CD; Kamm MA
    J Gastroenterol Hepatol; 2015 Feb; 30(2):268-78. PubMed ID: 25087692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some Gammaproteobacteria are enriched within CD14
    Sekido Y; Nishimura J; Nakano K; Osu T; Chow CT; Matsuno H; Ogino T; Fujino S; Miyoshi N; Takahashi H; Uemura M; Matsuda C; Kayama H; Mori M; Doki Y; Takeda K; Uchino M; Ikeuchi H; Mizushima T
    Sci Rep; 2020 Feb; 10(1):2988. PubMed ID: 32076066
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
    World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal barrier dysfunction in inflammatory bowel diseases.
    McGuckin MA; Eri R; Simms LA; Florin TH; Radford-Smith G
    Inflamm Bowel Dis; 2009 Jan; 15(1):100-13. PubMed ID: 18623167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential clustering of bowel biopsy-associated bacterial profiles of specimens collected in Mexico and Canada: what do these profiles represent?
    Bibiloni R; Tandon P; Vargas-Voracka F; Barreto-Zuniga R; Lupian-Sanchez A; Rico-Hinojosa MA; Guban J; Fedorak R; Tannock GW
    J Med Microbiol; 2008 Jan; 57(Pt 1):111-117. PubMed ID: 18065676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications.
    Balfour Sartor R
    J Clin Gastroenterol; 2007; 41 Suppl 1():S37-43. PubMed ID: 17438417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of 16S rDNA sequencing in microdissected bowel biopsies from Crohn's disease patients to assess bacterial flora diversity.
    De Hertogh G; Aerssens J; de Hoogt R; Peeters P; Verhasselt P; Van Eyken P; Ectors N; Vermeire S; Rutgeerts P; Coulie B; Geboes K
    J Pathol; 2006 Aug; 209(4):532-9. PubMed ID: 16739113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity.
    Geirnaert A; Calatayud M; Grootaert C; Laukens D; Devriese S; Smagghe G; De Vos M; Boon N; Van de Wiele T
    Sci Rep; 2017 Sep; 7(1):11450. PubMed ID: 28904372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.